Search results
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting...
NewMediaWire via Yahoo Finance· 3 weeks agoFREMONT, CA - (NewMediaWire) - April 10, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business...
NewMediaWire via Yahoo Finance· 2 months agoFREMONT CA - (NewMediaWire) - March 14, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
ABVC BioPharma Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoABVC BioPharma (NASDAQ:ABVC) Third Quarter 2022 Results Key Financial Results Net loss: US$3.70m...
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up...
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) announced new long-term data from the ALITHIOS open-label extension study of...